Free Trial

Immix Biopharma (IMMX) SEC Filings & 10K Form

Immix Biopharma logo
$1.99 -0.42 (-17.43%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.98 -0.01 (-0.75%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Immix Biopharma SEC Filings

DateFilerForm TypeView
05/19/2025
4:19 PM
Immix Biopharma (Filer)
Form 10-K/A
05/19/2025
4:21 PM
Immix Biopharma (Filer)
Form DEFA14A
05/19/2025
4:23 PM
Immix Biopharma (Filer)
Form 10-Q/A
05/19/2025
4:25 PM
Immix Biopharma (Filer)
Form ARS
05/08/2025
3:30 PM
Immix Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/29/2025
5:17 AM
HIRSCHMAN ORIN (Filed by)
Immix Biopharma (Subject)
Form SCHEDULE 13G/A
12/26/2024
3:20 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:45 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:45 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:16 PM
Immix Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
8:15 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:30 AM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:12 PM
Immix Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/19/2024
8:20 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:45 PM
Adams Helen C. (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
BUCHAN JANE (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Chudnovsky Yekaterina (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:30 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:00 AM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:00 AM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:00 AM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:00 AM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMMX) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners